Avalo Therapeutics, Inc. ($AVTX)
Filing Information
| Accession Number | 0001918845-26-000024 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 29, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
3,000
Total Value
$32,650.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jul 27, 2026 | Exercise/Conversion | 1,000 | $12.65 | $12,650.00 | 52,776 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jul 27, 2026 | Sale | 1,000 | $20.00 | $20,000.00 | 51,776 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Jul 27, 2026 | Exercise/Conversion | 1,000 | $0.00 | $0.00 | 124,750 | Direct | โ | View Details |